217 related articles for article (PubMed ID: 21045146)
21. HDAC Inhibitor Oxamflatin Induces Morphological Changes and has Strong Cytostatic Effects in Ovarian Cancer Cell Lines.
Wang YL; Liui HL; Fu RG; Wang ZW; Ren HT; Dai ZJ; Jing YY; Li Y
Curr Mol Med; 2016; 16(3):232-42. PubMed ID: 26917266
[TBL] [Abstract][Full Text] [Related]
22. TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer.
Ma Y; Xin Y; Li R; Wang Z; Yue Q; Xiao F; Hao X
Gene; 2014 Mar; 537(2):253-9. PubMed ID: 24406621
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of RECQL4-deficient fibroblasts from Rothmund-Thomson syndrome patients to genotoxic agents.
Jin W; Liu H; Zhang Y; Otta SK; Plon SE; Wang LL
Hum Genet; 2008 Jul; 123(6):643-53. PubMed ID: 18504617
[TBL] [Abstract][Full Text] [Related]
24. Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway.
Mo D; Fang H; Niu K; Liu J; Wu M; Li S; Zhu T; Aleskandarany MA; Arora A; Lobo DN; Madhusudan S; Balajee AS; Chi Z; Zhao Y
Cancer Res; 2016 May; 76(10):3057-66. PubMed ID: 27013200
[TBL] [Abstract][Full Text] [Related]
25. Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcoma.
Maire G; Yoshimoto M; Chilton-MacNeill S; Thorner PS; Zielenska M; Squire JA
Neoplasia; 2009 Mar; 11(3):260-8, 3p following 268. PubMed ID: 19242607
[TBL] [Abstract][Full Text] [Related]
26. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
27. Direct and indirect roles of RECQL4 in modulating base excision repair capacity.
Schurman SH; Hedayati M; Wang Z; Singh DK; Speina E; Zhang Y; Becker K; Macris M; Sung P; Wilson DM; Croteau DL; Bohr VA
Hum Mol Genet; 2009 Sep; 18(18):3470-83. PubMed ID: 19567405
[TBL] [Abstract][Full Text] [Related]
28. Rothmund-thomson syndrome responsible gene, RECQL4: genomic structure and products.
Kitao S; Lindor NM; Shiratori M; Furuichi Y; Shimamoto A
Genomics; 1999 Nov; 61(3):268-76. PubMed ID: 10552928
[TBL] [Abstract][Full Text] [Related]
29. Interaction between RECQL4 and OGG1 promotes repair of oxidative base lesion 8-oxoG and is regulated by SIRT1 deacetylase.
Duan S; Han X; Akbari M; Croteau DL; Rasmussen LJ; Bohr VA
Nucleic Acids Res; 2020 Jul; 48(12):6530-6546. PubMed ID: 32432680
[TBL] [Abstract][Full Text] [Related]
30. The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.
Lin PS; McPherson LA; Chen AY; Sage J; Ford JM
DNA Repair (Amst); 2009 Jul; 8(7):795-802. PubMed ID: 19376752
[TBL] [Abstract][Full Text] [Related]
31. RECQL4 helicase has oncogenic potential in sporadic breast cancers.
Arora A; Agarwal D; Abdel-Fatah TM; Lu H; Croteau DL; Moseley P; Aleskandarany MA; Green AR; Ball G; Rakha EA; Chan SY; Ellis IO; Wang LL; Zhao Y; Balajee AS; Bohr VA; Madhusudan S
J Pathol; 2016 Mar; 238(4):495-501. PubMed ID: 26690729
[TBL] [Abstract][Full Text] [Related]
32. Nuclear import and retention domains in the amino terminus of RECQL4.
Burks LM; Yin J; Plon SE
Gene; 2007 Apr; 391(1-2):26-38. PubMed ID: 17250975
[TBL] [Abstract][Full Text] [Related]
33. ATP-dependent helicase activity is dispensable for the physiological functions of Recql4.
Castillo-Tandazo W; Smeets MF; Murphy V; Liu R; Hodson C; Heierhorst J; Deans AJ; Walkley CR
PLoS Genet; 2019 Jul; 15(7):e1008266. PubMed ID: 31276497
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.
Lu H; Shamanna RA; de Freitas JK; Okur M; Khadka P; Kulikowicz T; Holland PP; Tian J; Croteau DL; Davis AJ; Bohr VA
Nat Commun; 2017 Dec; 8(1):2039. PubMed ID: 29229926
[TBL] [Abstract][Full Text] [Related]
35. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R
Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908
[TBL] [Abstract][Full Text] [Related]
36. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
[TBL] [Abstract][Full Text] [Related]
38. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
Feng W; Lu Z; Luo RZ; Zhang X; Seto E; Liao WS; Yu Y
Int J Cancer; 2007 Apr; 120(8):1664-8. PubMed ID: 17230502
[TBL] [Abstract][Full Text] [Related]
39. Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.
Bohrer LR; Chen S; Hallstrom TC; Huang H
Endocrinology; 2010 Nov; 151(11):5136-45. PubMed ID: 20881251
[TBL] [Abstract][Full Text] [Related]
40. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
